(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alector (ALEC) shares were down nearly 2% in Wednesday afternoon trade after Goldman Sachs initiated coverage of the stock at sell while setting the price...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alector (ALEC) said Tuesday that it has named Dr. Gary Romano as chief medical officer, effective May 23. According to the company, Romano will lead the...
| Address | 131 Oyster Point Boulevard South San Francisco, California 94080-2029 |
| Phone | +1.415.231.5660 |
| Number of Employees | N/A |
| Recent SEC Filing | 04/28/2022 DEF 14A |
| Chief Executive Officer & Director | Arnon Rosenthal |
| President, Head-Research & Development | Saraswati Kenkare-Mitra |
| Chief Financial, Accounting & Business Officer | Marc Edward Grasso |
| VP-Technology & Digital Health | Charles Wolfus |
| Price Open | $9.37 |
| Previous Close | $9.32 |
| 52 Week Range | $7.50 - 43.32 |
| Market Capitalization | $769.9 M |
| Shares Outstanding | 83.3 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/02/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.43 |
| Beta vs. S&P 500 | N/A |
| Revenue | $27.7 M |
| Net Profit Margin | -12.65% |
| Return on Equity | -10.57% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
